S&P Futures
3,795.00-21.75(-0.57%)Dow Futures
31,105.00-131.00(-0.42%)Nasdaq Futures
12,589.00-92.75(-0.73%)
Bausch Health Companies Inc. (BHC)
Chart Events
Performance Outlook
| Previous Close | 32.28 |
| Open | 32.28 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 3000 |
| Day's Range | 31.80 - 32.84 |
| 52 Week Range | 11.15 - 32.84 |
| Volume | 4,090,237 |
| Avg. Volume | 3,987,418 |
| Market Cap | 11.558B |
| Beta (5Y Monthly) | 1.37 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.58 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Nov 10, 2010 |
| 1y Target Est | 35.13 |
Fair Value
Related Research
- Simply Wall St.
What Type Of Shareholders Own The Most Number of Bausch Health Companies Inc. (NYSE:BHC) Shares?
Every investor in Bausch Health Companies Inc. ( NYSE:BHC ) should be aware of the most powerful shareholder groups...
- CNW Group
Innovation and ingenuity in structural engineering showcased in new mass timber office in Vancouver
Four-Storey Building Receives Support from NRCan's Green Construction through Wood ProgramVANCOUVER, BC, March 2, 2021 /CNW/ - The new head office for internationally-renowned structural engineering firm, Fast + Epp, is being recognized by the Canadian Wood Council and the BC forest industry for its innovation and ingenuity in wood design and building, and for being selected for funding support under Natural Resources Canada's Green Construction through Wood (GC Wood) Program. The hybrid mass timber building, located near downtown Vancouver on Yukon Street, is among the first office buildings in Vancouver to use mass timber as a structural material, and will showcase the same structural innovations and technologies that are at the forefront of their consulting practice.
- Barrons.com
Bausch Health and Landos Biopharma See Activist Action
Icahn Capital reached a pact to appoint Bausch Health directors. Perceptive Advisors disclosed a large stake in Landos Biopharma.
